loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 53fd1302 9e1b 4e04 B06d 1a706547c388 Applno 20164 Form Injectable Subcutaneous Dosage 120mg 0 8ml 150mg Ml - Drug Product Composition: Enoxaparin Sodium

    Menu

    Enoxaparin Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 22,653Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20164 / DOSAGE - INJECTABLE;SUBCUTANEOUS - 120MG/0.8ML (150MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    enoxaparin sodium(UNII: 8NZ41MIK1O)
    (enoxaparin - UNII:E47C0NF7LV)     		enoxaparin sodium150mg in 1 | 120mg in 0.8 | 300mg in 3 | 100mg in 1 | 80mg in 0.8 | 60mg in 0.6 | 40mg in 0.4 | 30mg in 0.3

    Inactive Ingredients

    Ingredient Name
    Fresenius Kabi USA, LLC
    Sandoz Inc
    sanofi-aventis U.S. LLC
    Actavis Pharma, Inc.
    Asclemed USA, Inc.
    BE Pharmaceuticals Inc.
    Cardinal Health
    Gland Pharma Limited
    Teva Parenteral Medicines, Inc.
    Zydus Pharmaceuticals USA Inc.
    BENZYL ALCOHOL(LKG8494WBH)       
    WATER(059QF0KO0R)